Eupraxia Pharmaceuticals Inc.
TSX:EPRX.TO
7.84 (CAD) • At close June 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 33.101 | 25.504 | 24.736 | 20.892 | 0.15 | 1.156 | 0.823 | 3.99 |
| Short Term Investments
| 0 | -6.162 | 0 | 9.009 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 33.101 | 19.342 | 24.736 | 29.901 | 0.15 | 1.156 | 0.823 | 3.99 |
| Net Receivables
| 0.329 | 0 | 0 | 0.337 | 0.487 | 1.032 | 1.089 | 1.043 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 1.107 | 0.271 | 0.236 | 0.484 | 0.656 | 0.237 | 0.289 | 0.217 |
| Total Current Assets
| 34.437 | 19.803 | 25.177 | 30.602 | 1.138 | 2.639 | 2.474 | 5.423 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 0.425 | 0.602 | 0.695 | 0.589 | 0.315 | 0.646 | 0.435 | 0.419 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.081 | 0.009 | 0.003 | 0.031 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets
| 0.506 | 0.611 | 0.699 | 0.62 | 0.315 | 0.646 | 0.435 | 0.419 |
| Total Assets
| 34.942 | 26.723 | 25.876 | 31.222 | 1.454 | 3.285 | 2.909 | 5.842 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short Term Debt
| 0.175 | 13.831 | 0.13 | 0.121 | 12.559 | 11.672 | 3.797 | 0.006 |
| Tax Payables
| 0 | 0.048 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0.004 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 3.032 | 11.663 | 4.012 | 2.146 | 9.984 | 8.994 | 10.548 | 0.725 |
| Total Current Liabilities
| 3.103 | 25.546 | 4.142 | 2.268 | 22.542 | 20.667 | 14.344 | 0.731 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 0 | 0 | 12.042 | 9.372 | 0.156 | 0.251 | 0 | 0.004 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | -1.672 | 0.03 | 0.419 | 0.498 | 0 | 0.001 |
| Total Non-Current Liabilities
| 0 | 0 | 10.37 | 9.401 | 0.575 | 0.749 | 0 | 0.005 |
| Total Liabilities
| 4.463 | 25.546 | 14.512 | 11.669 | 23.117 | 21.416 | 14.344 | 0.736 |
| Equity: | ||||||||
| Preferred Stock
| 31.705 | 0 | 2.786 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 116.36 | 92.914 | 92.337 | 80.713 | 23.798 | 23.548 | 23.548 | 23.586 |
| Retained Earnings
| -131.004 | -105.501 | -97.446 | -74.187 | -51.197 | -47.2 | -40.024 | -20.109 |
| Accumulated Other Comprehensive Income/Loss
| -5.984 | -3.586 | -2.786 | 16.56 | -0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 22.327 | 18.39 | 50.258 | 31.27 | 6.19 | 5.961 | 5.416 | 2.5 |
| Total Shareholders Equity
| 33.405 | 2.216 | 12.855 | 20.387 | -21.21 | -17.69 | -11.059 | 5.978 |
| Total Equity
| 31.839 | 0.462 | 11.364 | 19.553 | -21.664 | -18.131 | -11.435 | 5.106 |
| Total Liabilities & Shareholders Equity
| 34.942 | 26.723 | 25.876 | 31.222 | 1.454 | 3.285 | 2.909 | 5.842 |